The outcome of treatment of breast cancer in a developing country - Oman

Breast

Volumn 13, Issue 2, 2004, Pages 139-145

  Al Moundhri, A ^a   Al Bahrani, B ^a   Pervez, I ^a   Ganguly, S S ^a   Nirmala, V ^a   Al Madhani, A ^a   Al Mawalay, K ^a   Grant, C ^a  

^a SULTAN QABOOS UNIVERSITY   (Oman)

Author keywords

Breast cancer; Developing country; Oman

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; GOSERELIN; METHOTREXATE; MITOXANTRONE; PACLITAXEL; TAMOXIFEN; TRASTUZUMAB;

ADULT; AGE; ARTICLE; AWARENESS; AXILLARY LYMPH NODE; BREAST BIOPSY; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DEVELOPING COUNTRY; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MASTECTOMY; MULTIVARIATE ANALYSIS; OMAN; PARTIAL MASTECTOMY; PREDICTION; PREMENOPAUSE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; TREATMENT OUTCOME; TUMOR DIFFERENTIATION; TUMOR VOLUME;

EID: 1842588684     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2003.10.001     Document Type: Article

References (28)

1. Cheng SH, Tsou MH, Liu MC, et al. Unique features of breast cancer in Taiwan. Breast Cancer Res Treat 2000;63:213-23.
2. Seow A, Duffy SW, McGee MA, et al. Breast cancer in Singapore: Trends in incidence 1968-1992. Int J Epidemiol 1996;25:40-5.
3. Chow LW, Ting AC, Cheung KL, et al. Current status of breast cancer in Hong Kong. Chin Med J (Engl) 1997;110:474-8.
4. Ikpatt OF, Kuopio T, Collan Y. Proliferation in African breast cancer. Biology and prognostication in Nigerian breast cancer material. Mod Pathol 2002; 15:783-9.
5. Jin F, Devesa SS, Chow WH, et al. Cancer incidence trends in urban Shanghai, 1972-1994: An update. Int J Cancer 1999;83:435-40.
6. Malik IA. Clinico-pathological features of breast cancer in Pakistan. J Pak Med Assoc 2002;52:100-4.
7. Ibrahim EM, al-Mulhim FA a-AA, al-Muhanna FA, et al. Breast cancer in the eastern province of Saudi Arabia. Med Oncol 1998;15:241-7.
8. Fakhro AE, Fateha BE, Al-Asheeri N, et al. Breast cancer. Patient characteristics and survival analysis at Salmaniya Medical Complex, Bahrain. East Medit Health J 1999;5:430-9.
9. Ezzat AA, Ibrahim EM, Raja MA, et al. Locally advanced breast cancer in Saudi Arabia: High frequency of stage iii in a young population. Med Oncol 1999;16:95-103.
10. Tabar L, Yen MF, Vitak B, et al. Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. Lancet 2003;361:1405-10.
11. Jatoi I, Miller AB. Why is breast-cancer mortality declining? Lancet Oncol 2003;4:251-4.
12. Maalej M, Frikha H, Ben Salem S, et al. Breast cancer in Tunisia: Clinical and epidemiological study. Bull Cancer 1999;86:302-6.
13. Al-Lawati JA, Mohammed S-KC, et al. Cancer incidence in Oman. East Medit Health J 1999;5:1035-41.
14. Ministry of Health of the Sultanate of Oman. Cancer incidence in Oman, vol. 15. Muscat: Ministry of Health; 2001. p. 28-31.
15. Greene FL, Balch CM, Fleming ID, et al. Breast cancer. AJCC Cancer staging manual, 6th ed. Heidelberg: Springer; 2002. p. 220-4.
16. O'Malley CD, Le GM, Glaser SL, et al. Socioeconomic status and breast carcinoma survival in four racial/ethnic groups: A population-based study. Cancer 2003;97:1303-11.
17. Chu KC, Lamar CA, Freeman HP. Racial disparities in breast carcinoma survival rates. Separating factors that affect diagnosis from factors that affect treatment. Cancer 2003;97:2853-60.
18. Ezzat A, Raja MA, Zwaan F, et al. The lack of age as a significant prognostic factor in non-metastatic breast cancer. Eur J Surg Oncol 1998;24:23-7.
19. Garbay JR, Hacene K, Tubiana-Hulin M, et al. The factors in clinics' prediction in the cancer of the breast. Retrospective study of 5 609 cases. Bull Cancer 1994;81:1078-83.
20. Aaltomaa S, Lipponen P, Eskelinen M, et al. Mitotic indexes as prognostic predictors in female breast cancer. J Cancer Res Clin Oncol 1992;118:75-81.
21. Fisher B, Anderson S, Redmond CK, et al. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1995;333:1456-61.
22. Shannon C, Smith IE. Is there still a role for neoadjuvant therapy in breast cancer? Crit Rev Oncol Hematol 2003;45:77-90.
23. Fisher B, Saffer E, Rudock C, et al. Effect of local or systemic treatment prior to primary tumour removal on the production and response to a serum growth -stimulating factor. Cancer Res 1989;49:2002-4.
24. Hortobagyi GN, Ames FC, Buzdar AU, et al. Management of stage III primary breast cancer with primary chemotherapy, surgery and radiation therapy. Cancer 1988;62:2507-11.
25. Sandelin K, Apffelstaedt JP, Abdullah H, et al. Breast cancer in developing countries (Breast surgery international). Scand J Surg 2002;91:222-6.
26. Anderson BO, Braun S, Carlson RW, et al. Overview of breast health care guidelines for countries with limited resources. Breast J 2003;9(Suppl 2):S42.
27. Gajalakshmi CK. A Population-based survival study on female breast cancer in Madras, India. Br J Cancer 1997;75:771-5.
28. Knoll SM. Breast Cancer screening, a comprehensive breast cancer program in Saudi Arabia. Ann Saudi Med 1997;17: 1-3.